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Results: The number of responders was 145 (45%) and 28 
(49%), for the training and validation cohort, respectively. 
Feature space reduction resulted in a set of 34 highly robust 
and non-redundant features and subsequent model 
development lead to a multivariable model consisting of 8 
features (Table 1) with an out-of-sample AUC of 0.63±0.09. 
Independent validation resulted in an AUC of 0.77. Model 
derived ROC curves for both the training and validation 
cohort and overall AUC values are shown in Figure 1b. 
 
 
Conclusions: A multivariable model consisting only of 
radiomic features derived from pre-treatment FDG PET 
imaging predicted pathological response in LARC patients, 
which was independently validated in an external cohort. 
Radiomics may therefore facilitate early and accurate 
prediction of tumor response to treatment and identify 
patients eligible for a wait and see or organ preserving 
approach, or patients who may benefit from treatment 
intensification.  
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Purpose/Objective: To investigate the use of diffusion-
weighted imaging (DWI), 18F-fluorodeoxyglucose positron 
emission tomography/computed tomography (18F-FDG 
PET/CT) and molecular markers in the selection of patients 
with locally advanced rectal cancer (LARC) with good 
response to radiochemotherapy and who may be candidates 
for organ-preserving treatment. 
Materials and Methods: Patients with LARC were 
prospectively enrolled and were treated with RCT (45 Gy in 
fractions of 1.8 Gy; continuous infusion of 5-FU (225mg/m²)). 
DWI and 18F-FDG PET/CT scans were performed at three time 
points: prior to RCT, after 10-15 fractions and six weeks after 
the end of RCT. Additionally, tissue samples were obtained 
prior to RCT and at moment of surgery. Blood samples were 
collected prior to RCT, 2 weeks into and at the end of RCT. 
Total mesorectal excision (TME) was performed after an 
interval of 8 weeks. 
DWI scans were quantitatively evaluated by the apparent 
diffusion coefficient (ADC; b-values: 0-1000 s/mm²) and the 
tumor volume was measured on T2-weighted images. On the 
18F-FDG PET/CT scans, the tumor was delineated using an 
adapted treshold delineation method. DWI and 18F-FDG 
PET/CT parameters were compared with histopathologic 
findings after TME (pathological complete response (pCR) vs. 
no pCR; ypT0-1 vs. no ypT0-1) by using Mann-Whitney U tests. 
A p-value ≤0.05 was considered as statistically significant. 
Receiver-operating characteristics (ROC) analysis with the 
area under the curve (AUC) was employed to investigate the 
discriminatory capability of the various imaging parameters.  
Results: Overall, 70 patients were included. Eleven patients 
(16%) were considered as complete responders (9 pCR, 2 
cCR). Fifteen patients (21%) achieved ypT0-1 response. An 
increase in ADClow during RCT (ΔADC1-2low) was significantly 
associated with ypCR (mean 46% vs. 28%; p<0.05) and with 
ypT0-1 (46% vs. 26%; p=0.017) (Table 1). A similar increase 
was observed at time of surgery (ΔADC1-3low) for both ypCR ( 
82% vs 36%, p =0.002) and ypT0-1 (73% vs. 34%; p=0.002). T2-
volumetry was predictive for ypCR (Vpost p=0.034; ΔV1-3 
p=0.001) and for ypT0-1 (Vpre p=0.039; Vduring p=0.010; 
Vpost p<0.001; ΔV1-2 p=0.038; ΔV1-3 p<0.001). A late 
decrease in SUVmax, metabolic tumor volume and total lesion 
glycolysis (TLG) was predictive for ypCR (87% vs 71%, 
p=0.038; 98% vs 93%, p=0.027) and ypT0-1 (87% vs 67%, 
p<0.001; 98% vs 92%, p=0.001). 
Molecular analyses on blood (multiplex ELISA) and tissue 
markers (micro-arrays, IHC) are ongoing. By the time of the 
conference, we will integrate the most promising imaging 
parameters with blood and tissue markers in order to create 
a predictive model. 
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Conclusions: Both DWI and 18F-FDG PET/CT are useful tools 
to identify those patients who are candidates for a wait and 
see policy or a local excision. We hope to improve the 
predictive value of functional imaging by integrating them 
with molecular markers. 
Symposium: MR-only workflow in external-beam 
radiotherapy  
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The use of imaging is a crucial part of radiotherapy (RT), and 
it is used to localize both tumours and sensitive organs. 
Imaging is also the input to treatment planning calculations 
and for patient set-up. Magnetic resonance (MR) imaging 
provides excellent soft tissue contrast, and it also offers 
functional information of the tissues. Therefore, a major 
argument for replacing CT with MR in the RT process is the 
significantly improved spatial definition of target and risk 
organ volumes. However, in order to fully integrate MR into 
the RT workflow, CT-information also needs to be replaced 
by MR-data for accurate dose calculations and generation of 
reference images for patient positioning. Accordingly, the 
MR-only scenario in RT requires a substantial amount of 
research, development and hard work, before it can be 
brought into clinical practice. 
In Sweden, we have addressed the task by a national network 
called the “Gentle Radiotherapy” project, which was 
initiated in 2014. The aims of the project are to facilitate a 
fully integrated MR in the workflow of RT, and to promote 
the use of MR in clinical studies. The project is supported by 
the “Swedish Innovation Agency” (VINNOVA). The members of 
the consortium are six University Hospitals and six industrial 
partners. The work is divided into five dedicated work 
packages (WP): 1) Optimisation of sequences and protocols 
for RT applications, 2) MR-based treatment planning, 3) 
Image registration and automatic segmentation, 4) Q/A of 
MR-only workflow, and 5) ‘Functional MRI’ and clinical 
studies. About 50 researchers and clinicians are actively 
working in the five work packages, but even further scientists 
are involved. The mixture of clinical practice, academic 
science and industrial innovation creates a vibrant research 
environment. Besides the national project meetings, an 
educational series of web-based seminars on relevant topics 
of MR in RT is being developed. The expected final outcome 
of the project is clinical procedures, scientific research as 
well as new industrial products. The present status of the 
national Gentle radiotherapy project will be reviewed and a 
few results will be presented.  
In one subproject of Gentle Radiotherapy methods for 
creating CT equivalent data from MR-images are studied, i.e. 
synthetic CT images (sCT) for MR-only workflow. The 
Statistical Decomposition Algorithm (SDA) automatically 
decomposes and analyzes a standard type MRI image volume 
with respect to a plurality of tissue types, using a template 
assisted classification method. In a preliminary study, sCT 
images generated by the SDA were evaluated by comparing 
dosimetric accuracy between sCT and conventional CT for a 
set of six prostate tumor patients. Average mean absorbed 
dose difference to target was 0.1±0.2% (1 s.d.) between CT 
and sCT. Even with a restrictive gamma criteria (2% local 
dose/1mm), the pass rate was exceeding 99.9% in the 
transversal isocenter plane (superficial points excluded) for 
all cases. A study including more patients is in progress. This 
study is a good example of how an industrial partner works 
closely with academia/clinic in order to develop a new tool. 
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Introduction: Several different methods of mapping electron 
densities to MRI scans for dose calculation purposes have 
been proposed. These can be broadly grouped into 
classification based methods or atlas based methods. The 
classification methods estimate the tissue type from the MRI 
signal using single or multiple MRI scan sequences and assign 
an appropriate density. The atlas based methods use 
deformable image registration techniques to register single 
or multiple MRI atlas scans to a patient MRI scan and then 
assign densities. In this work a method that combines multi-
atlas deformable registration to the patient MR scan and 
